Skip to content

BAKER BROS. ADVISORS LP

Follow

13F filer, CIK 1263508, NEW YORK, NY

BAKER BROS. ADVISORS LP reported $21,044,442,318 across 80 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 77.25% of the portfolio.

Accepted , ingested 13F-HR 0001104659-26-128308

Period
2026-09-30
Reported value
$21B
Holdings
80
Top 10 weight
77.25%
New
5
Sold out
9

Part of the filer group BAKER BROS. ADVISORS LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KODadded+1,941,755$184M
CLDXadded+1,382,373$44.8M
TRAXnew+472,932$16.8M
SCTXnew+688,691$12.7M
FRNMnew+794,908$12.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CELCreduced-3,100,000-$247M
RVMDreduced-806,039-$165M
IMVTreduced-2,664,843-$90M
CRNXexited-2,351,465-$88M
ALMSexited-2,012,500-$56.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-128308, largest first. % of portfolio is the value over $21,044,442,318, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
INCYINCYTE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 30,739,466 shares; 2025Q1: 30,739,953 shares; 2025Q2: 30,743,275 shares; 2025Q3: 30,743,663 shares; 2025Q4: 30,743,991 shares; 2026Q1: 30,744,412 shares; 2026Q2: 30,762,330 shares; 2026Q3: 30,762,652 shares 30,762,652$3.73B17.74%+322Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,531,880 shares; 2025Q1: 8,799,053 shares; 2025Q2: 8,799,053 shares; 2025Q3: 8,799,053 shares; 2025Q4: 8,799,053 shares; 2026Q1: 8,799,053 shares; 2026Q2: 8,801,567 shares; 2026Q3: 8,832,335 shares 8,832,335$3.23B15.36%+30,768Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,936,972 shares; 2025Q1: 7,936,972 shares; 2025Q2: 9,364,972 shares; 2025Q3: 9,455,357 shares; 2025Q4: 9,455,357 shares; 2026Q1: 9,555,357 shares; 2026Q2: 11,443,357 shares; 2026Q3: 10,637,318 shares 10,637,318$2.18B10.38%-806,039Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 17,310,490 shares; 2025Q1: 17,310,490 shares; 2025Q2: 17,310,490 shares; 2025Q3: 17,310,490 shares; 2025Q4: 19,919,186 shares; 2026Q1: 19,919,186 shares; 2026Q2: 19,919,186 shares; 2026Q3: 21,860,941 shares 21,860,941$2.07B9.85%+1,941,7552026-11-05, Form 4: bought 4,703 shares on 2026-11-05 Timeline
MDGLMADRIGAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,974,590 shares; 2025Q1: 1,974,590 shares; 2025Q2: 1,976,018 shares; 2025Q3: 2,141,701 shares; 2025Q4: 2,141,701 shares; 2026Q1: 2,141,701 shares; 2026Q2: 2,143,131 shares; 2026Q3: 2,143,131 shares 2,143,131$1.08B5.13%02026-11-06, 13D/A: 2,330,144 shares, 9.99% of the class, 13D/A filed 2026-11-06 Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,006,863 shares; 2025Q1: 5,380,626 shares; 2025Q2: 7,712,900 shares; 2025Q3: 6,703,484 shares; 2025Q4: 6,592,746 shares; 2026Q1: 7,421,111 shares; 2026Q2: 8,796,111 shares; 2026Q3: 8,796,111 shares 8,796,111$1B4.77%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,995,929 shares; 2025Q1: 5,995,929 shares; 2025Q2: 6,651,429 shares; 2025Q3: 6,651,429 shares; 2025Q4: 8,657,242 shares; 2026Q1: 8,657,242 shares; 2026Q2: 8,657,242 shares; 2026Q3: 8,657,242 shares 8,657,242$968M4.6%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 42,877,916 shares; 2025Q1: 42,877,916 shares; 2025Q2: 42,896,690 shares; 2025Q3: 42,896,690 shares; 2025Q4: 42,896,690 shares; 2026Q1: 42,896,690 shares; 2026Q2: 42,912,904 shares; 2026Q3: 42,912,904 shares 42,912,904$865M4.11%0Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,630,125 shares; 2025Q1: 1,630,125 shares; 2025Q2: 1,630,125 shares; 2025Q3: 1,630,125 shares; 2025Q4: 2,085,333 shares; 2026Q1: 4,028,614 shares; 2026Q2: 4,028,614 shares; 2026Q3: 4,028,614 shares 4,028,614$564M2.68%0Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 24,424,865 shares; 2025Q1: 24,424,865 shares; 2025Q2: 33,722,974 shares; 2025Q3: 33,722,974 shares; 2025Q4: 36,391,063 shares; 2026Q1: 36,391,063 shares; 2026Q2: 32,786,348 shares; 2026Q3: 32,786,348 shares 32,786,348$554M2.63%0Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,084,249 shares; 2025Q1: 5,604,483 shares; 2025Q2: 5,604,483 shares; 2025Q3: 5,604,483 shares; 2025Q4: 5,604,483 shares; 2026Q1: 5,604,483 shares; 2026Q2: 5,604,483 shares; 2026Q3: 5,604,483 shares 5,604,483$534M2.54%0Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 331,533 shares; 2025Q1: 331,533 shares; 2025Q2: 689,488 shares; 2025Q3: 689,488 shares; 2025Q4: 1,126,488 shares; 2026Q1: 1,753,198 shares; 2026Q2: 1,753,198 shares; 2026Q3: 1,753,198 shares 1,753,198$511M2.43%0Timeline
ABCLABCELLERA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 27,525,640 shares; 2025Q1: 27,525,640 shares; 2025Q2: 27,525,640 shares; 2025Q3: 27,525,640 shares; 2025Q4: 27,525,640 shares; 2026Q1: 30,275,938 shares; 2026Q2: 33,012,138 shares; 2026Q3: 33,012,139 shares 33,012,139$482M2.29%+1Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,181,751 shares; 2025Q1: 4,483,285 shares; 2025Q2: 6,410,603 shares; 2025Q3: 8,091,351 shares; 2025Q4: 10,012,267 shares; 2026Q1: 10,012,267 shares; 2026Q2: 10,012,267 shares; 2026Q3: 10,012,267 shares 10,012,267$406M1.93%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,678,553 shares; 2025Q1: 4,257,735 shares; 2025Q2: 5,450,445 shares; 2025Q3: 7,915,792 shares; 2025Q4: 7,915,792 shares; 2026Q1: 7,915,792 shares; 2026Q2: 7,915,792 shares; 2026Q3: 4,815,792 shares 4,815,792$383M1.82%-3,100,000Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,818,323 shares; 2025Q1: 2,818,323 shares; 2025Q2: 2,824,669 shares; 2025Q3: 2,824,669 shares; 2025Q4: 2,826,246 shares; 2026Q1: 2,826,246 shares; 2026Q2: 2,834,643 shares; 2026Q3: 2,834,643 shares 2,834,643$211M1%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,062,123 shares; 2025Q1: 1,062,123 shares; 2025Q2: 2,118,728 shares; 2025Q3: 3,275,444 shares; 2025Q4: 3,618,826 shares; 2026Q1: 3,946,515 shares; 2026Q2: 5,010,030 shares; 2026Q3: 5,010,030 shares 5,010,030$192M0.91%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,155,940 shares; 2025Q1: 6,155,940 shares; 2025Q2: 7,305,940 shares; 2025Q3: 7,305,940 shares; 2025Q4: 6,575,940 shares; 2026Q1: 6,575,940 shares; 2026Q2: 3,701,719 shares; 2026Q3: 3,701,719 shares 3,701,719$150M0.71%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 11,045,336 shares; 2025Q1: 11,045,336 shares; 2025Q2: 11,045,336 shares; 2025Q3: 11,045,336 shares; 2025Q4: 11,045,336 shares; 2026Q1: 11,045,336 shares; 2026Q2: 11,045,336 shares; 2026Q3: 11,045,336 shares 11,045,336$146M0.69%0Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,767,773 shares; 2025Q1: 3,767,773 shares; 2025Q2: 3,767,773 shares; 2025Q3: 3,767,773 shares; 2025Q4: 5,555,017 shares; 2026Q1: 4,867,723 shares; 2026Q2: 4,716,831 shares; 2026Q3: 3,660,352 shares 3,660,352$134M0.64%-1,056,479Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 939,174 shares; 2025Q3: 1,670,762 shares; 2025Q4: 2,175,645 shares; 2026Q1: 1,992,783 shares; 2026Q2: 1,992,783 shares; 2026Q3: 1,709,053 shares 1,709,053$112M0.53%-283,730Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,882,125 shares; 2025Q1: 3,882,125 shares; 2025Q2: 3,882,125 shares; 2025Q3: 3,882,125 shares; 2025Q4: 4,658,556 shares; 2026Q1: 4,658,556 shares; 2026Q2: 4,658,556 shares; 2026Q3: 4,658,556 shares 4,658,556$110M0.52%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,707,881 shares; 2025Q1: 5,457,881 shares; 2025Q2: 5,457,881 shares; 2025Q3: 5,457,881 shares; 2025Q4: 5,457,881 shares; 2026Q1: 5,457,881 shares; 2026Q2: 5,435,220 shares; 2026Q3: 2,770,377 shares 2,770,377$93.6M0.44%-2,664,843Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 247,644 shares; 2025Q1: 247,644 shares; 2025Q2: 665,370 shares; 2025Q3: 665,370 shares; 2025Q4: 665,370 shares; 2026Q1: 665,370 shares; 2026Q2: 1,182,611 shares; 2026Q3: 2,564,984 shares 2,564,984$83.1M0.4%+1,382,373Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,731,695 shares; 2025Q1: 3,731,695 shares; 2025Q2: 3,731,695 shares; 2025Q3: 3,731,695 shares; 2025Q4: 3,731,695 shares; 2026Q1: 3,731,695 shares; 2026Q2: 3,734,336 shares; 2026Q3: 3,734,336 shares 3,734,336$77.2M0.37%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 789,759 shares; 2025Q3: 789,759 shares; 2025Q4: 789,759 shares; 2026Q1: 852,164 shares; 2026Q2: 852,164 shares; 2026Q3: 852,164 shares 852,164$75M0.36%0Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 550,090 shares; 2025Q3: 1,547,090 shares; 2025Q4: 1,547,090 shares; 2026Q1: 1,547,090 shares; 2026Q2: 1,547,090 shares; 2026Q3: 1,547,090 shares 1,547,090$52M0.25%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,916,095 shares; 2025Q1: 4,916,095 shares; 2025Q2: 4,916,095 shares; 2025Q3: 4,916,095 shares; 2025Q4: 4,345,736 shares; 2026Q1: 4,345,736 shares; 2026Q2: 4,345,736 shares; 2026Q3: 4,345,736 shares 4,345,736$51.8M0.25%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,160,117 shares; 2025Q1: 1,160,117 shares; 2025Q2: 1,160,117 shares; 2025Q3: 1,160,117 shares; 2025Q4: 1,160,117 shares; 2026Q1: 1,160,117 shares; 2026Q2: 2,826,783 shares; 2026Q3: 2,826,783 shares 2,826,783$51M0.24%0Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 357,915 shares; 2025Q1: 357,915 shares; 2025Q2: not reported; 2025Q3: 566,798 shares; 2025Q4: 1,791,841 shares; 2026Q1: 2,047,727 shares; 2026Q2: 2,047,727 shares; 2026Q3: 1,023,864 shares 1,023,864$45.7M0.22%-1,023,863Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 361,565 shares; 2025Q1: 361,565 shares; 2025Q2: 2,508,767 shares; 2025Q3: 1,556,109 shares; 2025Q4: 1,432,529 shares; 2026Q1: 1,432,529 shares; 2026Q2: 1,432,529 shares; 2026Q3: 1,432,529 shares 1,432,529$44.8M0.21%0Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 114,833 shares; 2025Q1: 114,833 shares; 2025Q2: 114,833 shares; 2025Q3: 114,833 shares; 2025Q4: 271,406 shares; 2026Q1: 905,191 shares; 2026Q2: 905,191 shares; 2026Q3: 905,191 shares 905,191$41.5M0.2%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,885,357 shares; 2025Q1: 10,885,357 shares; 2025Q2: 10,885,357 shares; 2025Q3: 10,885,357 shares; 2025Q4: 10,885,357 shares; 2026Q1: 10,885,357 shares; 2026Q2: 10,885,357 shares; 2026Q3: 10,885,357 shares 10,885,357$40.1M0.19%0Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,123,824 shares; 2025Q1: 10,123,824 shares; 2025Q2: 10,123,824 shares; 2025Q3: 10,123,824 shares; 2025Q4: 10,123,824 shares; 2026Q1: 10,123,824 shares; 2026Q2: 10,123,824 shares; 2026Q3: 10,123,824 shares 10,123,824$39.6M0.19%0Timeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 190,476 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 445,975 shares; 2026Q2: 445,975 shares; 2026Q3: 445,975 shares 445,975$38.1M0.18%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,743,725 shares; 2025Q1: 1,743,725 shares; 2025Q2: 1,712,882 shares; 2025Q3: 1,712,882 shares; 2025Q4: 2,233,099 shares; 2026Q1: 2,585,978 shares; 2026Q2: 2,678,430 shares; 2026Q3: 2,988,144 shares 2,988,144$37.6M0.18%+309,714Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,275,830 shares; 2025Q1: 7,275,830 shares; 2025Q2: 10,168,901 shares; 2025Q3: 12,094,094 shares; 2025Q4: 12,094,094 shares; 2026Q1: 10,916,693 shares; 2026Q2: 9,508,565 shares; 2026Q3: 4,256,682 shares 4,256,682$37.4M0.18%-5,251,883Timeline
STOKSTOKE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,633,838 shares; 2025Q1: 4,633,838 shares; 2025Q2: 4,633,838 shares; 2025Q3: 4,633,838 shares; 2025Q4: 3,336,697 shares; 2026Q1: 3,336,697 shares; 2026Q2: 3,336,697 shares; 2026Q3: 1,313,999 shares 1,313,999$34.2M0.16%-2,022,698Timeline
TRDAENTRADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,865,819 shares; 2025Q1: 4,865,819 shares; 2025Q2: 4,865,819 shares; 2025Q3: 4,865,819 shares; 2025Q4: 5,072,730 shares; 2026Q1: 5,072,730 shares; 2026Q2: 5,072,730 shares; 2026Q3: 5,072,730 shares 5,072,730$32.2M0.15%0Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 674,450 shares; 2025Q1: 1,486,200 shares; 2025Q2: 991,691 shares; 2025Q3: 991,691 shares; 2025Q4: 991,691 shares; 2026Q1: 991,691 shares; 2026Q2: 991,691 shares; 2026Q3: 991,691 shares 991,691$27.6M0.13%0Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 670,431 shares; 2025Q1: 670,431 shares; 2025Q2: 670,431 shares; 2025Q3: 1,102,106 shares; 2025Q4: 1,102,106 shares; 2026Q1: 1,102,106 shares; 2026Q2: 1,102,106 shares; 2026Q3: 1,102,106 shares 1,102,106$27.5M0.13%0Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,286,411 shares; 2026Q3: 803,425 shares 803,425$23.9M0.11%-482,986Timeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,134,803 shares; 2026Q1: 2,134,803 shares; 2026Q2: 2,134,803 shares; 2026Q3: 2,134,803 shares 2,134,803$23M0.11%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 77,050 shares; 2025Q1: 77,050 shares; 2025Q2: 337,050 shares; 2025Q3: 337,050 shares; 2025Q4: 337,050 shares; 2026Q1: 349,657 shares; 2026Q2: 349,657 shares; 2026Q3: 349,657 shares 349,657$22.9M0.11%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 270,000 shares; 2026Q1: 415,621 shares; 2026Q2: 844,816 shares; 2026Q3: 844,816 shares 844,816$21.8M0.1%0Timeline
GENBGENERATE BIOMEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,423,602 shares; 2026Q2: 1,423,602 shares; 2026Q3: 1,423,602 shares 1,423,602$21.4M0.1%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,004,756 shares; 2025Q1: 4,004,756 shares; 2025Q2: 4,004,756 shares; 2025Q3: 4,004,756 shares; 2025Q4: 4,004,756 shares; 2026Q1: 4,004,756 shares; 2026Q2: 4,004,756 shares; 2026Q3: 4,004,756 shares 4,004,756$19.5M0.09%0Timeline
AKTSAKTIS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 996,351 shares; 2026Q2: 996,351 shares; 2026Q3: 996,351 shares 996,351$19.4M0.09%0Timeline
JBIOJADE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,641,137 shares; 2026Q1: 1,641,137 shares; 2026Q2: 1,230,426 shares; 2026Q3: 1,230,426 shares 1,230,426$17.3M0.08%0Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,461,425 shares; 2025Q1: 1,461,425 shares; 2025Q2: 1,461,425 shares; 2025Q3: 1,461,425 shares; 2025Q4: 1,461,425 shares; 2026Q1: 1,461,425 shares; 2026Q2: 1,461,425 shares; 2026Q3: 1,461,425 shares 1,461,425$17.2M0.08%0Timeline
TRAXFIRST TRACKS BIOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 472,932 shares 472,932$16.8M0.08%newTimeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000$16.1M0.08%0Timeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 100,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 903,400 shares; 2026Q1: 607,788 shares; 2026Q2: 607,788 shares; 2026Q3: 607,788 shares 607,788$14.2M0.07%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 211,267 shares; 2026Q3: 211,267 shares 211,267$13.9M0.07%0Timeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 993,679 shares; 2025Q1: 347,408 shares; 2025Q2: 370,208 shares; 2025Q3: 370,208 shares; 2025Q4: 370,208 shares; 2026Q1: 370,208 shares; 2026Q2: 370,208 shares; 2026Q3: 370,208 shares 370,208$13.8M0.07%0Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,484,226 shares; 2025Q3: 4,250,826 shares; 2025Q4: 4,250,826 shares; 2026Q1: 4,975,826 shares; 2026Q2: 4,975,826 shares; 2026Q3: 4,975,826 shares 4,975,826$13.5M0.06%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 672,096 shares; 2025Q1: 672,096 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 813,449 shares; 2026Q1: 813,449 shares; 2026Q2: 813,449 shares; 2026Q3: 813,449 shares 813,449$13.1M0.06%0Timeline
SCTXSCRIBE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 688,691 shares 688,691$12.7M0.06%newTimeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 794,908 shares 794,908$12.5M0.06%newTimeline
MPLTMAPLIGHT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 364,705 shares; 2026Q1: 364,705 shares; 2026Q2: 364,705 shares; 2026Q3: 1,166,763 shares 1,166,763$11.9M0.06%+802,058Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 45,031 shares; 2025Q1: 45,031 shares; 2025Q2: 368,923 shares; 2025Q3: 368,923 shares; 2025Q4: 368,923 shares; 2026Q1: 119,743 shares; 2026Q2: 119,743 shares; 2026Q3: 119,743 shares 119,743$11.8M0.06%0Timeline
SERASERA PROGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,434,399 shares; 2025Q1: 5,498,170 shares; 2025Q2: 5,498,170 shares; 2025Q3: 5,498,170 shares; 2025Q4: 5,498,170 shares; 2026Q1: 5,498,170 shares; 2026Q2: 5,498,170 shares; 2026Q3: 5,498,170 shares 5,498,170$11.5M0.05%0Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 847,390 shares; 2026Q2: 847,390 shares; 2026Q3: 1,234,794 shares 1,234,794$10.2M0.05%+387,404Timeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 644,116 shares; 2025Q1: 644,116 shares; 2025Q2: 2,675,674 shares; 2025Q3: 2,746,674 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 930,232 shares; 2026Q3: 829,053 shares 829,053$10M0.05%-101,179Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 350,000 shares; 2026Q3: 350,000 shares 350,000$9.97M0.05%0Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 550,000 shares; 2026Q3: 550,000 shares 550,000$8.43M0.04%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 333,333 shares; 2026Q3: 333,333 shares 333,333$8.32M0.04%0Timeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 200,000 shares; 2025Q4: 200,000 shares; 2026Q1: 200,000 shares; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$7.68M0.04%0Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 536,832 shares; 2025Q1: 536,832 shares; 2025Q2: 536,832 shares; 2025Q3: 536,832 shares; 2025Q4: 971,614 shares; 2026Q1: 971,614 shares; 2026Q2: 971,614 shares; 2026Q3: 1,843,795 shares 1,843,795$5.62M0.03%+872,181Timeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,477,339 shares; 2025Q1: 19,351,087 shares; 2025Q2: 12,883,844 shares; 2025Q3: 10,008,345 shares; 2025Q4: 10,008,345 shares; 2026Q1: 10,008,345 shares; 2026Q2: 6,395,431 shares; 2026Q3: 2,333,155 shares 2,333,155$5.55M0.03%-4,062,276Timeline
VTVTVTV THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 97,314 shares; 2025Q1: 97,314 shares; 2025Q2: 97,314 shares; 2025Q3: 148,314 shares; 2025Q4: 148,314 shares; 2026Q1: 148,314 shares; 2026Q2: 148,314 shares; 2026Q3: 148,314 shares 148,314$4.57M0.02%0Timeline
QTTBQ32 BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 547,945 shares 547,945$4.53M0.02%newTimeline
EIKNEIKON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 555,555 shares; 2026Q2: 555,555 shares; 2026Q3: 555,555 shares 555,555$4.47M0.02%0Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 55,306 shares; 2026Q3: 55,306 shares 55,306$1.19M0.01%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,380,949 shares; 2025Q1: 2,030,949 shares; 2025Q2: 2,030,949 shares; 2025Q3: 2,030,949 shares; 2025Q4: 310,483 shares; 2026Q1: 310,483 shares; 2026Q2: 310,483 shares; 2026Q3: 310,483 shares 310,483$905K<0.01%0Timeline
TCRXTSCAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,784,792 shares; 2025Q1: 2,784,792 shares; 2025Q2: 2,784,792 shares; 2025Q3: 2,784,792 shares; 2025Q4: 2,784,792 shares; 2026Q1: 2,784,792 shares; 2026Q2: 2,784,792 shares; 2026Q3: 2,784,792 shares 2,784,792$876K<0.01%0Timeline
ALGSALIGOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 83,055 shares; 2025Q1: 83,055 shares; 2025Q2: 83,055 shares; 2025Q3: 83,055 shares; 2025Q4: 83,055 shares; 2026Q1: 83,055 shares; 2026Q2: 83,055 shares; 2026Q3: 83,055 shares 83,055$468K<0.01%0Timeline
SKYESKYE BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 196,905 shares 196,905$317K<0.01%newTimeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,607 shares; 2025Q1: 10,607 shares; 2025Q2: 10,607 shares; 2025Q3: 10,607 shares; 2025Q4: 10,607 shares; 2026Q1: 10,607 shares; 2026Q2: 10,607 shares; 2026Q3: 10,607 shares 10,607$232K<0.01%0Timeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
CELCUITY INCCELCUITY INC NOTE 2.750% 8/0principal30,750,000$55.5M0

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CRNXCRINETICS PHARMACEUTICALS IN2,351,465$88Mshares
ALMSALUMIS INC2,012,500$56.6Mshares
VRDNVIRIDIAN THERAPEUTICS INC2,383,025$43.8Mshares
SIONSIONNA THERAPEUTICS INC400,000$17.6Mshares
VSTMVERASTEM INC2,499,338$9.55Mshares
SGMTSAGIMET BIOSCIENCES INC952,996$7.37Mshares
WVEWAVE LIFE SCIENCES LTD822,638$4.78Mshares
SKYESKYE BIOSCIENCE INC1,575,243$1.09Mshares
SRZNWSURROZEN INC833,333$13.8Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-128308 base2026-11-16